15
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10724 | Cdc7-IN-1 | CDK | |
Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death. | |||
T9064 | LY3143921 hydrate | CDK | |
LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro anticancer activity [1]. | |||
T61224 | Cdc7-IN-8 | ||
Cdc7-IN-8, a potent inhibitor, targets Cdc7, a serine/threonine kinase responsible for activating MCM promotion through phosphorylation of the microchromosome maintenance protein (MCM protein). MCM protein, an essential ... | |||
T62230 | Cdc7-IN-10 | ||
Cdc7-IN-10 is a potent inhibitor of Cdc7 (IC50 ≤ 1 nM) and can be used in studies of proliferative diseases. | |||
T60815 | Cdc7-IN-9 | ||
Cdc7-IN-9 can be used for the research of cancer which is a potent inhibitor of Cdc7 [1]. | |||
T62231 | Cdc7-IN-11 | ||
Cdc7-IN-11 is a potent inhibitor of Cdc7 (IC50 ≤ 1 nM) and can be used in the study of proliferative diseases. | |||
T60427 | Cdc7-IN-15 | ||
Cdc7-IN-15 (Example 108) is an inhibitor of cdc7 kinase that has potential to be used for cancer research [1]. | |||
T61223 | Cdc7-IN-19 | ||
Cdc7-IN-19 (compound 1-1) is a potent CDC7 inhibitor with an IC 50 of 1.49 nM [1]. | |||
T61289 | Cdc7-IN-14 | ||
Cdc7-IN-14 (compound 82) is a highly potent inhibitor of CDC7, demonstrating an IC50 value of less than 1 nM. This compound, Cdc7-IN-14, exhibits promising potential for cancer research [1]. | |||
T60659 | Cdc7-IN-12 | ||
Cdc7-IN-12 (compound 1) is a potent inhibitor of CDC7 (IC 50 of <1 nM) that has the potential in the cancer research. Cdc7-IN-12 exhibits antiproliferative activities in COLO205 cells with IC 50 of 100-1000 nM [1]. | |||
T61288 | Cdc7-IN-13 | ||
Cdc7-IN-13 (compound 84) is a highly potent CDC7 inhibitor, exhibiting an IC50 value of <1 nM. This compound holds promise for cancer research [1]. | |||
T61436 | Cdc7-IN-18 | ||
Cdc7-IN-18 (compound 1-2) is a highly effective inhibitor of the CDC7 enzyme. It has an IC 50 value of 1.29 nM for the Cdc7/DBF4 enzyme. In addition, this compound exhibits strong antiproliferative activities, with an IC... | |||
T60589 | Cdc7-IN-17 | ||
Cdc7-IN-17 is a potent inhibitor of CDC7 with an IC 50 of <10 μM that can be used in cancer research [1]. | |||
T61435 | (S)-Cdc7-IN-18 | ||
(S)-Cdc7-IN-18, a potent CDC7 inhibitor, effectively impedes the overactivation of MCM2, a crucial tumor cell marker, induced by huCdc7 overexpression. Consequently, it inhibits the aberrant proliferation of tumor cells.... | |||
T60747 | LY3143921 | ||
LY3143921 ((S)-Example 2) is an orally active inhibitor of CDC7 kinase with broad in vitro anticancer activity [1]. |